1. Home
  2. WB vs MPLT Comparison

WB vs MPLT Comparison

Compare WB & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weibo Corporation

WB

Weibo Corporation

HOLD

Current Price

$6.64

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$13.00

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WB
MPLT
Founded
2009
2018
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
WB
MPLT
Price
$6.64
$13.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$14.00
$32.67
AVG Volume (30 Days)
1.3M
571.1K
Earning Date
05-28-2026
05-28-2026
Dividend Yield
7.49%
N/A
EPS Growth
N/A
82.39
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.35
N/A
Revenue Next Year
$1.73
N/A
P/E Ratio
$5.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.62
$9.10
52 Week High
$12.96
$40.43

Technical Indicators

Market Signals
Indicator
WB
MPLT
Relative Strength Index (RSI) 20.29 44.43
Support Level N/A $10.67
Resistance Level $7.78 $20.20
Average True Range (ATR) 0.11 0.95
MACD -0.03 0.80
Stochastic Oscillator 5.22 89.76

Price Performance

Historical Comparison
WB
MPLT

About WB Weibo Corporation

Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: